NGS Automation Market Worth $940.2 Million by 2029

1. NGS Automation Market Worth $940.2 Million by 2029

2. NGS Automation Market – 2022-2029 According to a new market research report, ‘NGS Automation Market By Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Global Forecast to 2029', published by Meticulous Research®, the NGS automation market is expected to grow at a CAGR of 13.4% from 2022 to reach $940.2 million by 2029. Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample- report/cp_id=5271 Next-generation sequencing (NGS) includes processes such as sample pre-processing, library preparation, sequencing, and bioinformatics. The library preparation step is critical in NGS workflow; however, it is still time-consuming and repetitive despite ongoing technical advancements in high- throughput sequencing. The library preparation step has numerous repetitive steps that require small volumes to be pipetted with high precision. This process makes it highly prone to manual errors, compromising the entire NGS process. The automation of library preparation can increase efficiency, generate more consistent results, and increase lab efficiency. NGS automation also helps maintain turnaround times and increase sample throughput. The main factors driving the NGS automation market are the increasing demand for automation in NGS workflow, the rising incidences of cancer, and the increasing R&D investments and healthcare expenditure. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the requirement of high-skilled personnel for operating automation software are the major challenges to the growth of this market. The Impact of COVID-19 on the NGS Automation Market The outbreak of the COVID-19 pandemic and the emergence of new COVID-19 variants has highlighted the importance of next-generation sequencing in identifying and keeping track of the SARS-COV-2 virus mutations. Since 2020, various COVID-19 variants have been identified using next-generation sequencing. Companies have been actively collaborating to support the demand for accurate and widespread testing. For instance, in August 2020, Beckman Coulter, Inc. (U.S.) collaborated with Fry Laboratories, LLC (U.S.) and BioID Genomics, Inc. (U.S.) for developing a rapid NGS diagnostics technology for the detection of COVID-19. Through this collaboration, Beckman Coulter shared its expertise in automation and integrated it with Fry Laboratories’ NGS library preparation technologies. Speak Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5271 to our Analysts to Understand the Impact of COVID-19 on Your The NGS automation market is segmented based on product, application, sequencing type, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level. Based on product, in 2022, the workstation/robotic platform segment is estimated to account for the largest share of the NGS automation market. Based on application, in 2022, the drug discovery segment is estimated to account for the largest share of the NGS automation market.. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. NGS Automation Market – 2022-2029 Based on sequencing type, in 2022, the whole genome sequencing segment is estimated to account for the largest share of the overall NGS automation market. Based on end user, in 2022, the pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the NGS automation market. Based on geography, in 2022, North America is estimated to account for the largest share of the NGS automation market, followed by Europe and Asia-Pacific. The report also includes an extensive assessment of the product, application, sequencing type, end user, and geography, and key strategic developments adopted by leading market participants in the industry over the past four years (2019–2022). In recent years, the NGS automation market has witnessed numerous product launches, agreements, collaborations, partnerships, and acquisitions. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/ngs-automation-market-5271 Scope of the Report: NGS Automation Market, by Product •Workstation/Robotic Platform •Reagents & Consumables NGS Automation Market, by Application •Drug Discovery •Clinical Diagnostics oOncology oInfectious Diseases oReproductive Health oOther Clinical Diagnostics •Other Applications NGS Automation Market, by Sequencing Type •Whole Genome Sequencing •Whole Exome Sequencing •Targeted Genome Sequencing •Others NGS Automation Market, by End User •Hospitals & Diagnostic Laboratories Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. NGS Automation Market – 2022-2029 •Pharmaceutical and Biotechnology Companies •Academic Research Institutes •Others End Users NGS Automation Market, by Geography •North America oU.S. oCanada •Europe oGermany oFrance oU.K. oItaly oSpain oRest of Europe (RoE) •Asia Pacific oChina oJapan oIndia oRest of APAC (RoAPAC) •Latin America •Middle East & Africa Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample- report/cp_id=5271 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com